| WNT as a driver and dependency in cancer MJ Parsons, T Tammela, LE Dow Cancer discovery 11 (10), 2413-2429, 2021 | 193 | 2021 |
| An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants MP Zafra, MJ Parsons, J Kim, D Alonso-Curbelo, S Goswami, EM Schatoff, ... Cancer discovery 10 (11), 1654-1671, 2020 | 112 | 2020 |
| Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community … E Domingo, C Camps, PJ Kaisaki, MJ Parsons, D Mouradov, MM Pentony, ... The Lancet Gastroenterology & Hepatology 3 (9), 635-643, 2018 | 77 | 2018 |
| Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes DS Williams, D Mouradov, RN Jorissen, MR Newman, E Amini, ... Gut 68 (3), 465-474, 2019 | 71 | 2019 |
| MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors A Sakthianandeswaren, MJ Parsons, D Mouradov, RN MacKinnon, ... Cancer discovery 8 (8), 988-1005, 2018 | 57 | 2018 |
| MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer A Sakthianandeswaren, MJ Parsons, D Mouradov, OM Sieber Oncotarget 9 (69), 33056, 2018 | 19 | 2018 |
| MACROD2 haploinsufficiency impairs catalytic activity of PARP1 and promotes chromosome instability and growth of intestinal tumors. Cancer Discov. 2018; 8: 988–1005. doi: 10 … A Sakthianandeswaren, MJ Parsons, D Mouradov, RN MacKinnon, ... CD-17-0909.[Abstract][CrossRef][Academic Search], 0 | 15 | |
| An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants. Cancer Discov. 2020; 10: 1654–1671. doi: 10.1158/2159-8290 MP Zafra, MJ Parsons, J Kim, D Alonso-Curbelo, S Goswami, EM Schatoff, ... CD-20-0442.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 6 | |
| WNT as a driver and dependency in Cancer. Cancer Discov. 2021; 11 (10): 2413–29.34518209 10.1158/2159-8290 MJ Parsons, T Tammela, LE Dow CD-21-0190PMC8487948, 0 | 6 | |
| Wnt as a driver and dependency in cancer. Cancer Discov 11 (10): 2413–2429 MJ Parsons, T Tammela, LE Dow | 5 | 2021 |
| WNT as a driver and dependency in cancer. Cancer Discov. 2021; 11: 2413–2429. doi: 10.1158/2159-8290 MJ Parsons, T Tammela, LE Dow CD-21-0190.[DOI][PMC free article][PubMed][Academic Search], 0 | 5 | |
| Identification of clinically relevant colon cancer genes predictve of improved relapse free survival MJ Parsons Cancer Research 77 (13_Supplement), 4386-4386, 2017 | 1 | 2017 |
| Abstract B080: Mutant-selective KRASG12D(ON) inhibitor suppresses proliferation in vitro and tumor growth in vivo of KrasG12D GEMM-derived PDAC organoids MP Labrecque, L Jiang, N Nasholm, B Nayak, X Yu, A Song, C Weller, ... Cancer Research 84 (2_Supplement), B080-B080, 2024 | | 2024 |
| Mutant-selective KRASG12D (ON) inhibitor suppresses proliferation in vitro and tumor growth in vivo of KrasG12D GEMM-derived PDAC organoids MP Labrecque, L Jiang, N Nasholm, B Nayak, X Yu, A Song, C Weller, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Abstract A014: Identifying and overcoming resistance to RAS targeted therapy in colorectal cancer MJ Parsons, M Zafra, S Goswami, MTC Fernandez, JE Wilkinson, LE Dow Cancer Research 82 (23_Supplement_1), A014-A014, 2022 | | 2022 |
| Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent E Domingo, C Camps, P Kaisaki, M Parsons, D Mouradov, M Pentony, ... Lancet Gastroenterology and Hepatology 3 (9), 2018 | | 2018 |
| Genomics study to identify novel cancer genes predictive for prognosis and 5-FU benefit in stage II/III colorectal cancer M Parsons, O Sieber, D Mouradov European Journal of Cancer 61, S180, 2016 | | 2016 |
